{"id":"W2074269068","doi":"10.1016/j.cllc.2013.08.001","title":"A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non–Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium","year":2013,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal General Hospital; University of Toronto; University of Ottawa; McGill University; Ottawa Hospital","funders":"AstraZeneca","keywords":"Medicine; Lung cancer; Internal medicine; Proto-oncogene tyrosine-protein kinase Src; Oncology; Chemotherapy; Cancer; Kinase; Population; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002375482,0.001517113,0.001735866,0.0004081133,0.0005843023,0.001173028,0.001021034,0.00176496,0.00466485],"category_scores_gemma":[0.001144669,0.0004846781,0.001505327,0.0003845897,0.0009869786,0.0009978965,0.0005008727,0.003871888,0.000950079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001123013,"about_ca_system_score_gemma":0.001828335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00194902,"about_ca_topic_score_gemma":0.006175391,"domain_scores_codex":[0.999527,0.0002352568,0.00001395067,0.00007467984,0.00004273551,0.0001064148],"domain_scores_gemma":[0.998974,0.0001397902,0.000121717,0.00007014556,0.00006595261,0.0006284743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7109367,0.05574522,0.01166153,0.000958046,0.002390022,0.0006827298,0.0005347515,0.005480335,0.03702716,0.0009889598,0.03975289,0.1338417],"study_design_scores_gemma":[0.8245077,0.1492986,0.01547067,0.00003692881,0.000429242,0.0004406385,0.0001156264,0.001867105,0.00195368,0.0004324878,0.005409881,0.00003741489],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863234,0.002141726,0.0005293264,0.002590955,0.0002628056,0.002510031,0.002316605,0.000103754,0.003221596],"genre_scores_gemma":[0.9701554,0.002641471,0.002530538,0.003949698,0.0003325941,0.003922048,0.008916729,0.00007107412,0.00748031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00466485,"threshold_uncertainty_score":0.01560545,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02339027935434116,"score_gpt":0.4181057393726841,"score_spread":0.394715460018343,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}